Pediatrics Articles

Pediatrics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fujinaga H et al. – Hyperoxia decreases growth and disrupts VEGF–NO signaling in human preterm ECFCs. VEGF treatment restores growth in hyperoxia by increasing NO production. And NO treatment also increases growth during hyperoxia. Exogenous VEGF or NO may protect preterm ECFCs from the adverse effects of hyperoxia and preservation of ECFC function may improve outcomes of preterm infants.

Today in Pediatric Pulmonology...keeping you current

Foreign body aspirations in Infancy: a 20-year experience
International Journal of Medical Sciences , 11/25/09

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans
Journal of Allergy and Clinical Immunology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address